Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Anti-Müllerian hormone levels in women with polycystic ovarian syndrome compared with normal women of reproductive age in China.

Tian X, Ruan X, Mueck AO, Wang J, Liu S, Yin D, Lu Y, Wu H, Zhang Y.

Gynecol Endocrinol. 2014 Feb;30(2):126-9. doi: 10.3109/09513590.2013.864273. Epub 2013 Dec 4.

PMID:
24303884
2.

[Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].

Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.

Akush Ginekol (Sofiia). 2013;52 Suppl 1:16-23. Bulgarian.

PMID:
24294740
3.

The relationship between Anti-Müllerian hormone and other reproductive parameters in normal women and in women with polycystic ovary syndrome.

Koutlaki N, Dimitraki M, Zervoudis S, Poiana C, Psillaki A, Nikas I, Liberis A, Badiu C, Liberis V.

J Med Life. 2013 Jun 15;6(2):146-50. Epub 2013 Jun 25.

4.

Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.

Pierre A, Peigné M, Grynberg M, Arouche N, Taieb J, Hesters L, Gonzalès J, Picard JY, Dewailly D, Fanchin R, Catteau-Jonard S, di Clemente N.

Hum Reprod. 2013 Mar;28(3):762-9. doi: 10.1093/humrep/des460. Epub 2013 Jan 14.

5.

[Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].

Parahuleva N, Pehlivanov B, Orbecova M, Uchikova E, Ivancheva H.

Akush Ginekol (Sofiia). 2014;53(5):22-7. Bulgarian.

PMID:
25558667
6.

Serum anti-Müllerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China.

Tian X, Ruan X, Mueck AO, Wallwiener D, Wang J, Liu S, Yin D, Lu Y, Zhang Y, Wu H.

Gynecol Endocrinol. 2014 Nov;30(11):836-9. doi: 10.3109/09513590.2014.943719. Epub 2014 Jul 21.

PMID:
25045796
7.

The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.

Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe Andersen A.

Hum Reprod. 2014 Apr;29(4):791-801. doi: 10.1093/humrep/det469. Epub 2014 Jan 16.

8.

The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women.

Bungum L, Franssohn F, Bungum M, Humaidan P, Giwercman A.

PLoS One. 2013 Sep 4;8(9):e68223. doi: 10.1371/journal.pone.0068223. eCollection 2013.

9.

Change of anti-Mullerian-hormone levels during follicular phase in PCOS patients.

Köninger A, Koch L, Enekwe A, Birdir C, Kasimir-Bauer S, Kimmig R, Strowitzki T, Schmidt B.

Gynecol Endocrinol. 2015 Jan;31(1):26-30. doi: 10.3109/09513590.2014.959436. Epub 2014 Sep 15.

PMID:
25222840
10.

Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.

Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D.

Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E238-43. doi: 10.1152/ajpendo.90684.2008. Epub 2008 Oct 28.

11.

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.

Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.

Hum Reprod. 2005 Jul;20(7):1820-6. Epub 2005 Mar 31.

12.

Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome.

Cui Y, Shi Y, Cui L, Han T, Gao X, Chen ZJ.

Fertil Steril. 2014 Jul;102(1):230-236.e2. doi: 10.1016/j.fertnstert.2014.03.032. Epub 2014 Apr 18.

PMID:
24746743
13.

Comparing serum basal and follicular fluid levels of anti-Müllerian hormone as a predictor of in vitro fertilization outcomes in patients with and without polycystic ovary syndrome.

Arabzadeh S, Hossein G, Rashidi BH, Hosseini MA, Zeraati H.

Ann Saudi Med. 2010 Nov-Dec;30(6):442-7. doi: 10.4103/0256-4947.71063.

15.

Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.

Tal R, Seifer DB, Khanimov M, Malter HE, Grazi RV, Leader B.

Am J Obstet Gynecol. 2014 Jul;211(1):59.e1-8. doi: 10.1016/j.ajog.2014.02.026. Epub 2014 Mar 2.

PMID:
24593938
16.

Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.

Bhide P, Dilgil M, Gudi A, Shah A, Akwaa C, Homburg R.

Fertil Steril. 2015 Feb;103(2):537-41. doi: 10.1016/j.fertnstert.2014.10.033. Epub 2014 Nov 20.

PMID:
25467043
17.

Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.

Sahmay S, Atakul N, Aydogan B, Aydin Y, Imamoglu M, Seyisoglu H.

Acta Obstet Gynecol Scand. 2013 Dec;92(12):1369-74. doi: 10.1111/aogs.12247. Epub 2013 Oct 15.

PMID:
23980726
18.

The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.

Nardo LG, Yates AP, Roberts SA, Pemberton P, Laing I.

Hum Reprod. 2009 Nov;24(11):2917-23. doi: 10.1093/humrep/dep225. Epub 2009 Jul 18.

19.

Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome.

Somunkiran A, Yavuz T, Yucel O, Ozdemir I.

Eur J Obstet Gynecol Reprod Biol. 2007 Oct;134(2):196-201. Epub 2007 Mar 1.

PMID:
17335955
20.

Clinical significance of serum concentration of anti-Müllerian hormone in obese women with polycystic ovary syndrome.

El-Halawaty S, Rizk A, Kamal M, Aboulhassan M, Al-Sawah H, Noah O, Al-Inany H.

Reprod Biomed Online. 2007 Nov;15(5):495-9.

PMID:
18028738
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk